Add Company
Join Now

Vascugen Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vascugen's estimated annual revenue is currently $1.4M per year.(i)
  • Vascugen's estimated revenue per employee is $155,000

Employee Data

  • Vascugen has 9 Employees.(i)
  • Vascugen grew their employee count by -25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M5-17%N/AN/A
#2
$5.7M376%N/AN/A
#3
$10.2M666%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$2M130%N/AN/A
#6
$7.6M49-2%N/AN/A
#7
$0.8M5-17%N/AN/A
#8
$7.9M516%N/AN/A
#9
$37.7M243-2%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells. Our vasculogenic cells have the potential to directly address ischemic disease conditions and to serve as a novel platform for delivery of therapeutic payloads in cardiovascular, solid tumor, and other indications. Vascugen's research and development facility includes an integrated manufacturing facility for early-stage clinical manufacture of our products.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vascugen's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Project ManagerReveal Email/Phone
3
Operations ManagerReveal Email/Phone
4
Assoc. Director R&DReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M9-44%$18M
#2
$0.7M90%N/A
#3
$0.7M90%N/A
#4
$75M90%N/A
#5
$0.7M9-44%N/A